These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1688117

  • 1. Clinical findings. Abnormalities of the mental state and movement disorder and their correlates.
    Johnstone EC, Owens DG, Frith CD, Leary J.
    Br J Psychiatry Suppl; 1991 Oct; (13):21-5, 44-6. PubMed ID: 1688117
    [No Abstract] [Full Text] [Related]

  • 2. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC, Honer WG.
    J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
    [No Abstract] [Full Text] [Related]

  • 3. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H, Bourgeois M.
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [Abstract] [Full Text] [Related]

  • 4. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR, Liddle PF, Curson DA, Patel M.
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract] [Full Text] [Related]

  • 5. [Increased blink rate in schizophrenic patients].
    Mackert A, Woyth C, Flechtner KM, Frick K.
    Nervenarzt; 1990 Jul; 61(7):426-30. PubMed ID: 1975431
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of schizophrenia from the viewpoint of the patient. Studies on the course of treatment and neuroleptic treatment from a personal perspective].
    Windgassen K.
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1989 Jul; 58():1-169. PubMed ID: 2576099
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Exacerbation of catatonic symptoms in neuroleptic therapy].
    Bräunig P, Krüger S, Höffler J.
    Nervenarzt; 1995 May; 66(5):379-82. PubMed ID: 7609820
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ICI 204,636: a new atypical antipsychotic drug.
    Hirsch SR, Link CG, Goldstein JM, Arvanitis LA.
    Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Implications for the pharmacotherapy of schizophrenia.
    Rep Group Adv Psychiatry (1984); 1992 May; (134):35-58. PubMed ID: 1348372
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuroleptic-induced emesis: a new indication for clozapine?
    Bustillo JR, Buchanan RW.
    Biol Psychiatry; 1995 Aug 01; 38(3):194-5. PubMed ID: 7578665
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S, Adler L, Angrist B, Peselow E, Rotrosen J.
    J Clin Psychiatry; 1989 Jan 01; 50(1):26-7. PubMed ID: 2562952
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T, Brown KW, Woods JP.
    Acta Psychiatr Scand; 1991 May 01; 83(5):377-9. PubMed ID: 1677232
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.